COM:ENOCHIANBIO
Renovaro Biosciences
- Stock
Last Close
0.70
04/08 19:58
Market Cap
45.38M
Beta: -
Volume Today
87.29K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Jun '16 | Jun '17 | Jun '18 | Jun '19 | Jun '20 | Jun '21 | Jun '22 | Jun '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|
revenue | 42.77K - | |||||||||
cost of revenue | 295.66K - | 5.28K 98.22% | ||||||||
gross profit | -295.66K - | 37.49K 112.68% | ||||||||
selling and marketing expenses | ||||||||||
general and administrative expenses | 2.11M - | 1.33M 37.25% | 2.57M 93.93% | 4.69M 82.42% | 8.42M 79.39% | 7.12M 15.43% | 7.74M 8.70% | 14.33M 85.14% | 15.32T 106,897,392.85% | |
selling general and administrative expenses | 2.11M - | 1.33M 37.25% | 2.57M 93.93% | 4.69M 82.42% | 8.42M 79.39% | 7.12M 15.43% | 7.74M 8.70% | 14.33M 85.14% | 15.32T 106,897,392.85% | |
research and development expenses | 804.19K - | 62.76K 92.20% | 616.96K 883.00% | 2.50M 304.91% | 4.69M 87.92% | 15.54M 231.00% | 8.37M 46.11% | 4.17T 49,746,663.33% | ||
other expenses | 18.98K - | 27.39K 44.33% | 14.53K 46.97% | 2.86M 19,575.89% | 71.71K 97.49% | 108.58K 51.42% | 123.53K 13.77% | 123.59K 0.04% | 19.07T 15,432,879,582.82% | |
cost and expenses | 2.43M - | 2.16M 10.93% | 2.65M 22.50% | 8.17M 208.23% | 10.99M 34.53% | 11.92M 8.50% | 23.40M 96.26% | 22.83M 2.46% | 38.56T 168,915,033.50% | |
operating expenses | 2.13M - | 2.16M 1.17% | 2.65M 22.79% | 8.17M 208.23% | 10.99M 34.53% | 11.92M 8.50% | 23.40M 96.26% | 22.83M 2.46% | 38.56T 168,915,033.50% | |
interest expense | 84.55K - | 2.36K 97.20% | 26.26K 1,010.79% | 143.26K 445.57% | 43 99.97% | 104.28K 242,411.63% | 379.61K 264.03% | 372.84K 1.78% | -580.34B 155,653,402.72% | |
ebitda | -2.38M - | -2.09M 11.97% | -2.64M 25.91% | -5.27M 99.74% | -10.84M 105.98% | -11.76M 8.48% | -23.00M 95.47% | -22.58M 1.81% | -38.44T 170,249,862.80% | |
operating income | -2.43M - | -2.12M 12.69% | -2.65M 24.97% | -8.17M 208.23% | -10.99M 34.53% | -11.92M 8.50% | -23.40M 96.26% | -116.08M 396.03% | -38.56T 33,215,923.19% | |
depreciation and amortization | 45.20K - | 27.39K 39.39% | 14.53K 46.97% | 2.90M 19,891.26% | 145.20K 95.00% | 158.88K 9.42% | 404.59K 154.65% | 93.50M 23,009.25% | 113.50B 121,287.87% | |
total other income expenses net | -40.58K - | -74.73K 84.15% | 218.98K 393.02% | -1.09M 599.69% | -7.03M 542.14% | 507.41K 107.22% | -3.45M 779.35% | 2.65M 176.76% | -1.13T 42,601,617.18% | |
income before tax | -2.55M - | -2.20M 13.75% | -2.46M 11.81% | -9.26M 276.92% | -18.02M 94.49% | -11.42M 36.63% | -26.85M 135.18% | -113.43M 322.49% | -39.68T 34,984,367.27% | |
income tax expense | -177.54K - | -462.79K 160.67% | -64.88K 85.98% | -111.72K 72.20% | 7.10M 6,455.30% | 104.28K 98.53% | -125.28K 220.13% | 34 100.03% | ||
net income | -2.37M - | -1.74M 26.81% | -2.39M 37.90% | -9.15M 282.47% | -25.12M 174.44% | -11.52M 54.13% | -26.72M 131.96% | -113.43M 324.47% | -39.68T 34,984,356.78% | |
weighted average shs out | 7.50M - | 9.53M 27.11% | 12.27M 28.67% | 21.94M 78.87% | 37.55M 71.15% | 46.33M 23.38% | 47.17M 1.81% | 52.53M 11.37% | 56.27M 7.11% | |
weighted average shs out dil | 7.50M - | 9.53M 27.11% | 12.27M 28.67% | 21.94M 78.87% | 37.55M 71.15% | 46.33M 23.38% | 47.17M 1.81% | 52.53M 11.37% | 56.27M 7.11% | |
eps | -0.32 - | -0.18 43.75% | -0.20 11.11% | -0.42 110.00% | -0.67 59.52% | -0.25 62.69% | -0.57 128.00% | -2.16 278.95% | -705.30K 32,652,756.94% | |
epsdiluted | -0.32 - | -0.18 43.75% | -0.20 11.11% | -0.42 110.00% | -0.67 59.52% | -0.25 62.69% | -0.57 128.00% | -2.16 278.95% | -705.30K 32,652,756.94% |
All numbers in USD (except ratios and percentages)